NKTREUR Nektar Therapeutics

held by 1 manager in Q1 2021

Manager	% of their portfolio	Held	Activity	Value	Shares
Stanley Druckenmiller Duquesne Family Office	0.44%	3 mo	NEW	$20M	1,000,000

Search